Gut Liver.
2014 Nov;8(6):580-581. 10.5009/gnl14377.
Ribonucleotide Reductase Subunit M2 Can Be New Molecular Target and Prognostic Biomarker of Hepatocellular Carcinoma
- Affiliations
-
- 1Department of Internal Medicine, The Catholic University of Korea College of Medicine, Seoul, Korea. cwkim@catholic.ac.kr
- KMID: 2070072
- DOI: http://doi.org/10.5009/gnl14377
Abstract
- No abstract available.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- High Expression of Ribonucleotide Reductase Subunit M2 Correlates with Poor Prognosis of Hepatocellular Carcinoma
- Functions of Herpesvirus-Encoded Homologs of the Cellular Ribonucleotide Reductase Large Subunit
- Comparative Analysis of the Three Classes of Archaeal and Bacterial Ribonucleotide Reductase from Evolutionary Perspective
- C4orf46 is a Potential Prognostic Biomarker for Liver Hepatocellular Carcinoma
- Value of TMEM115 as a Potential Prognostic Biomarker in Liver Hepatocellular Carcinoma
